Federal Drug Price Negotiation Implications for Medicare Part D.

Format:

Book

Government document

Author/Creator:

Library of Congress. Congressional Research Service

Language:

English

Subjects (All):

Competition.

Medical economics.

Public contracts.

Physical Description:

1 online resource

Contained In:

ProQuest U.S. Congressional Research Digital Collection

Place of Publication:

[Place of publication not identified] [publisher not identified] 2007

Summary:

Describes how Federal Government negotiates drug prices under existing public programs, presents arguments for and against such activities, and analyzes implications for pharmaceutical industry, Medicare beneficiaries, and others if similar Federal involvement were to occur for the Medicare Part D program under the Medicare Prescription Drug, Improvement, and Modernization Act. Summarizes recent legislative activity

Notes:

CRS Report

Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed Dec. 2010). Reuse except for individual research requires license from ProQuest, LLC

Vendor supplied data

Other Format:

Microfiche version Library of Congress Congressional Research Service Federal Drug Price Negotiation

Publisher Number:

CRS-2007-DSP-0360

Access Restriction:

Restricted for use by site license